INTRODUCTION Tadalafil is a potent and selective phosphodiesterase-5 (PDE-5) inhibitor, asecondary messenger for the smoothmuscle relaxing effects of nitric oxide,which plays an important role in thevasodilation of erectile tissues.1-3 OralPDE-5 inhibitors have become the preferredfirst-line treatment for erectile dysfunction worldwide.4

more at...http://www.allfordrugs.com/
http://www.allfordrugs.com/2015/03/11/tadalafil-analyticalspectral-visit/
PREPARATION 
Diastereoselective synthesis of (+)-tadalafil (1)describes a process for the synthesis of tadalafil (1) and itsintermediate of formula5which involves reactingD-tryptophan methylester 2 with a piperonal 3 in the presence of methanol and conc. HCl to
give compound 4 . The later compound is then reacted with chloroacetyl chloride in the presence of NaHCO 3
to afford the intermediate5, which is reacted with methylamine in chloroform to give tadalafil in 88% yield
depicts an efficient and stereospecific synthesis of tadalafil (1)as well as 12a-epi-tadalafil (11). Pictet–Spengler reaction ofD-trypto-phan methyl ester hydrochloride9with equal molar piperonal byrefluxing for 4 h in nitromethane affordedcis-10-HCl in 98% ee and94% yield. The hydrochloride salt ofcistetrahydro-b-carboline deriva-tivecis-10-HCl was directly treated with 1.5 equiv of chloroacetyl chlo-ride in dichloromethane at 0o
C in the presence of 3 equiv oftriethylamine to formN-chloroacetyl tetrahydro-b-carboline derivative5
in 92% yield. Then compound5reacted with 5 equiv of methylamineovernight in DMF at room temperature to furnish tadalafil1in95% yields.
US PATENT
D. Ben-Zion, D. Dov, United States Patent, US 2006/0276652 A1, 2006.
B.D. Pandurang, B.B. Bharat, S.S. Sachin, P.S. Pranay, United States Patent, US 7, 223,
863 B2, 2007.
FROM L TRYPTOPHAN
X. Sen, S. Xiao-Xin, X. Jing, Y. Jing-Jing, L. Shi-Ling, L. Wei-Dong, Tetrahedron
Asymmetr. 20 (2009) 2090.
S. Xiao-Xin, L. Shi-Ling, X. Wei, X. Yu-Lan, Tetrahedron Asymmetr. 19 (2008) 435
S. Xiao, X. Lu, X.-X. Shi, Y. Sun, L.-L. Liang, X.-H. Yu, J. Dong, Tetrahedron Asymmetr.
20 (2009) 430.
more at...http://www.allfordrugs.com/
http://www.allfordrugs.com/2015/03/11/tadalafil-analyticalspectral-visit/
more at...http://www.allfordrugs.com/
http://www.allfordrugs.com/2015/03/11/tadalafil-analyticalspectral-visit/
No comments:
Post a Comment